Published in
Springer (part of Springer Nature), Cancer Chemotherapy and Pharmacology, 2(79), p. 421-429
DOI: 10.1007/s00280-017-3241-9
Links
Tools
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
Journal article published in 2017 by
Ghassan K. Abou-Alfa,
Chia-Jui Yen,
Chih-Hung Hsu,
Joseph O’Donoghue,
Volkan Beylergil,
Shutian Ruan,
Neeta Pandit-Taskar,
Bolorsukh Gansukh,
Serge K. Lyashchenko,
Jennifer Ma,
Peter Wan,
Yu-Yun Shao 
,
Zhong-Zhe Lin,
Catherine Frenette,
Bert O’Neil
and other authors.
,
Zhong-Zhe Lin,
Catherine Frenette,
Bert O’Neil
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 